SCHEMBL25587724

SCHEMBL25587724

CC[C@]1(O)[C@H](n2cnc3c(N)ncnc32)O[C@](C)(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@H]1O

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 6/20 0.57
▸ P2RY2 P41231 5/20 0.57
▸ P2RY11 Q96G91 1/20 0.57
▸ P2RX1 P51575 4/20 0.55
▸ P2RX3 P56373 4/20 0.55
▸ P2RX4 Q99571 3/20 0.55
▸ P2RX2 Q9UBL9 2/20 0.52
▸ SRC P12931 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ RNASEL Q05823 1/20 0.49
▸ MACROD2 A1Z1Q3 1/20 0.47
▸ SIRT6 Q8N6T7 1/20 0.47
▸ MACROD1 Q9BQ69 1/20 0.47
▸ TRPM2 O94759 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18672074 0.87 P2RY1 (0.56) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL16368322 0.87 P2RY1 (0.56) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL16644376 0.87 P2RY1 (0.58) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL16374101 0.87 P2RY1 (0.56) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL23171662 0.83 P2RY1 (0.59) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL16368363 0.83 P2RY1 (0.59) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL17384915 0.82 P2RY1 (0.64) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL16368340 0.82 P2RY1 (0.55) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL25566017 0.82 ADORA2A (0.44) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL21078487 0.81 P2RY1 (0.59) P2RY1P2RY2P2RY11P2RX1P2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3013340-B9 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF JANSSEN PHARMACEUTICALS INC (US) 2023-10-04 — — EP disclosed
EP-3013340-B1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF JANSSEN BIOPHARMA INC (US) 2023-06-07 — — EP disclosed
Send feedback